@article {e001701corr1, editor = {,}, title = {Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany}, volume = {9}, number = {10}, elocation-id = {e001701corr1}, year = {2021}, doi = {10.1136/jitc-2020-001701corr1}, publisher = {BMJ Specialist Journals}, URL = {https://jitc.bmj.com/content/9/10/e001701corr1}, eprint = {https://jitc.bmj.com/content/9/10/e001701corr1.full.pdf}, journal = {Journal for ImmunoTherapy of Cancer} }